Financial Statements — ACT
Balance Sheet
(in billions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 |
|---|
| Cash & Equivalents | 0.55 | 0.54 | 0.61 | 0.64 | 0.67 | 0.70 | 0.61 | 0.68 | 0.69 | 0.62 | 0.54 | 0.58 | 0.44 | 0.45 |
| Short-term Investments | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | -- | -- | 0.01 |
| Total Assets | 6.96 | 6.88 | 6.77 | 6.72 | 6.60 | 6.35 | 6.30 | 6.00 | 5.92 | 5.84 | 5.72 | 5.76 | 5.79 | 5.99 |
| Long-term Debt | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.75 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 |
| Total Liabilities | 1.62 | 1.56 | 1.55 | 1.60 | 1.56 | 1.52 | 1.59 | 1.54 | 1.55 | 1.55 | 1.61 | 1.68 | 1.74 | 1.79 |
| Retained Earnings | 3.82 | 3.53 | 3.40 | 3.26 | 2.99 | 2.84 | 2.69 | 2.53 | 2.40 | 2.25 | 2.16 | 1.99 | 1.81 | 1.70 |
| Total Stockholder Equity | 5.34 | 5.32 | 5.22 | 5.12 | 5.04 | 4.83 | 4.71 | 4.46 | 4.38 | 4.30 | 4.12 | 4.08 | 4.05 | 4.20 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 |
|---|
| Net Premiums Earned | 242.85 | 245.74 | 244.69 | 245.29 | 244.79 | 245.74 | 249.06 | 244.57 | 240.75 | 240.10 | 243.35 | 238.52 | 235.11 | 232.74 | 235.06 | 237.39 | 234.28 | 236.86 | 243.06 |
| Net Investment Income | 70.91 | 68.62 | 68.61 | 65.88 | 63.04 | 62.62 | 61.06 | 59.77 | 57.11 | 56.16 | 54.95 | 50.92 | 45.34 | 44.90 | 39.49 | 35.78 | 35.15 | 35.25 | 35.99 |
| Total Revenue | 312.07 | 312.71 | 311.46 | 304.89 | 306.78 | 301.78 | 309.59 | 298.83 | 291.58 | 296.19 | 299.04 | 277.52 | 280.94 | 276.84 | 275.08 | 273.54 | 269.59 | 272.84 | 280.31 |
| Benefits & Claims | 37.16 | 17.81 | 35.89 | 25.29 | 30.54 | 23.81 | 12.16 | (16.82) | 19.50 | 24.37 | 17.85 | (4.07) | (10.98) | 18.10 | (40.31) | (61.56) | (10.45) | 5.97 | 34.12 |
| Total Benefits & Expenses | 98.69 | 89.62 | 101.63 | 90.39 | 95.36 | 93.92 | 80.13 | 64.01 | 85.66 | 96.45 | 85.93 | 63.38 | 56.43 | 94.06 | 30.43 | 12.65 | 59.68 | 77.97 | 105.70 |
| Tax Provision | 45.61 | 45.92 | 46.33 | 46.69 | 45.64 | 45.12 | 48.79 | 51.16 | 44.93 | 42.44 | 48.91 | 46.13 | 48.53 | 38.98 | 53.66 | 56.15 | 45.28 | 41.34 | 37.40 |
| Net Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 204.74 | 164.63 | 153.53 | 137.21 |
| Diluted EPS | 1.18 | 1.23 | 1.10 | 1.11 | 1.08 | 1.05 | 1.15 | 1.16 | 1.01 | 0.97 | 1.02 | 1.04 | 1.08 | 0.88 | 1.17 | 1.25 | 1.01 | 0.95 | 0.84 |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 |
|---|
| Operating Cash Flow | 224.04 | 186.27 | 192.01 | 119.52 | 226.72 | 166.13 | 188.14 | 144.70 | 187.30 | 190.06 | 154.80 | 167.85 | 119.34 | 158.44 | 100.33 | 140.95 | 160.80 | 161.04 | 411.08 |
| Investing Cash Flow | (125.48) | 10.07 | (121.26) | (25.61) | (89.57) | (136.90) | (102.35) | 32.20 | (113.47) | (95.42) | (136.33) | (31.11) | 33.46 | 26.27 | (125.70) | 25.67 | (146.50) | 13.51 | (412.29) |
| Financing Cash Flow | (132.01) | (157.41) | (140.14) | (116.21) | (101.31) | (103.16) | (111.46) | (92.20) | (75.18) | (156.94) | (31.89) | (66.94) | (44.96) | (206.71) | (22.80) | (22.80) | 0.00 | (200.29) | 0.00 |
Dividends Per Share
(USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 |
|---|
| Dividends Per Share | 0.21 | 0.21 | 0.21 | 0.19 | 0.87 | 0.19 | 0.19 | 0.16 | 0.16 | 0.14 | 0.14 |
